Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

KRSA holding history

Korsana Biosciences, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KRSA overviewAll 13F holders of KRSAFull Q4 2025 holdings

Shares (Q4 2025)
23,490
Value
$29.8K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of KRSA by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 202523,490$29.8K<0.1%00.0%UnchangedHolders
Q3 202523,490$54.0K<0.1%00.0%UnchangedHolders
Q2 202523,490$68.4K<0.1%00.0%UnchangedHolders
Q1 202523,490$58.0K<0.1%00.0%UnchangedHolders
Q4 202423,490$75.6K<0.1%00.0%UnchangedHolders
Q3 202423,490$60.6K<0.1%00.0%UnchangedHolders
Q2 202423,490$54.0K<0.1%00.0%UnchangedHolders
Q1 202423,490$75.2K<0.1%00.0%UnchangedHolders
Q4 202323,490$78.7K<0.1%−17,041−42.0%ReducedHolders
Q3 202340,531$138.6K<0.1%−40,638−50.1%ReducedHolders
Q2 202381,169$334.4K<0.1%−1,408−1.7%ReducedConverted for a 1-for-20 splitHolders
Q1 20231,651,536$716.6K<0.1%00.0%UnchangedHolders
Q4 20221,651,536$1.08M<0.1%+832+0.1%AddedHolders
Q3 20221,650,704$1.42M<0.1%−103,449−5.9%ReducedHolders
Q2 20221,754,153$963.0K<0.1%00.0%UnchangedHolders
Q1 20221,754,153$1.95M<0.1%−116,210−6.2%ReducedHolders
Q4 20211,870,363$3.22M<0.1%+438,334+30.6%AddedHolders
Q3 20211,432,029$4.40M<0.1%+8,497+0.6%AddedHolders
Q2 20211,423,532$5.55M<0.1%−245,607−14.7%ReducedHolders
Q1 20211,669,139$4.66M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.